Company: HCTI
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001213900-25-021346
Chunk: 5

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 5
---
 only one copy of the Notice of Internet Availability of Proxy Materials, Proxy Statement, and Annual Report on Form 10-K for the year ended December 31, 2023, as applicable, is being delivered to multiple stockholders sharing an address unless we have received contrary instructions. We will promptly deliver a separate copy of any of these documents to you if you write to us at Healthcare Triangle, Inc., 7901 Stoneridge Drive, Suite 

# 220, Pleasanton, California 94588, Attn: Investor Relations, or call 925-270-4812, or email IR@healthcaretriangle.com.                                                                                                                                                                                                                                |
|                               |     | If you want to receive separate copies of the Notice of Internet Availability of Proxy Materials, Proxy Statement, or Annual Report on Form 10-K in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker, or other nominee record holder, or you may contact us at the above address or telephone number.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

4

PROPOSAL ONE — ELECTION OF DIRECTORS Number of Directors; Board Structure Our amended certificate of incorporation and bylaws provide that the number of our directors shall be fixed from time to time by a resolution of our Board of Directors or of the stockholders. Our Board of Directors currently consists of four (4) members, three (3) of whom qualify as “independent” under the listing standards of the Nasdaq Capital Market (“ Nasdaq”). Directors serve until the next annual meeting and until their successors are elected and qualified or until they die, retire or are removed. All of our current directors’ terms expire at this Annual Meeting. Directors who are elected at this Annual Meeting will have terms that will expire at our 2025 Annual Meeting. The following presents our current directors, ages and positions as of February 24, 2025

| Name                     |     | Age |     | Position                            |
| Dave Rosa(1)(2*)         |     |  59 |     | Chairman of the Board of Directors. |
| Shibu Kizhakevilayil     |     |  53 |     | Head of M&A and Director            |
| Ronald McClurg(1*)(2)(3) |     |  64 |     | Director                            |
| Jainal Bhuiyan(1)(3*)    |     |  42 |     | Director                            |

____________ (1)Member